Nūhou

ʻO ka 92nd China International Medical Equipment Fair (CMEF), i manaʻo nui ʻia ʻo ka barometer honua o ka ʻoihana olakino, e mālama ʻia mai Kepakemapa 26 a 29 ma ka Canton Fair Complex ma Guangzhou, Kina. Ma lalo o ke kumuhana “Health · Innovat...

Ua hoʻonohonoho ʻia ka holomua AI o Kina i mea hoʻololi pāʻani no ka ʻike ʻana i ka maʻi maʻi maʻi mua HANGZHOU -- Ma kahi hoʻomohala ʻāina no ka ʻenehana lapaʻau, ua wehe nā mea noiʻi Kina i kahi ʻōnaehana naʻauao hana e hiki ai ke ʻike i ka maʻi maʻi ʻōpū o ka wā mua.

Me ka piʻi nui ʻana o nā hihia o ka maʻi diabetes i nā makahiki he 18 i hala iho nei, ke koi nei ka poʻe loea lapaʻau Kina i ka poʻe e hoʻohana i ka nohona olakino. Ua ʻike ʻia kahi noiʻi hou he 233 miliona mau kānaka ma Kina i loaʻa i ka maʻi maʻi i ka makahiki 2023, kahi piʻi he 163 pakeneka mai 2005.

I kēia mau lā, ua paʻi ka Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences i kahi hopena noiʻi groundbreaking ma Nature Nanotechnology. ʻO ka ʻōnaehana nanorobot magnetic i hoʻomohala ʻia e lākou no ka manawa mua i hoʻokō i kahi lapaʻau piha piha o ka "keʻeʻe i ka pale koko-lolo - hoʻokele pololei - hoʻopaʻa ʻia", lawe mai i kahi hopena kipi i nā maʻi lolo e like me ka maʻi o Alzheimer.

Wakinekona, Iune 12, 2024 - Ua hoʻonui ka US Food and Drug Administration (FDA) i kēia lā i ka ʻae ʻana o ka gene therapy "SOD1-ASO" (inoa inoa ʻo Toferson) i hoʻomohala ʻia e Swiss pharmaceutical giant Novartis no ka mālama ʻana i ka amyotrophic lateral sclerosis (ALS) i hoʻokumu ʻia e nā mutations i ka superoxide dismutase 1 gene. ʻO kēia ka lāʻau lapaʻau gene therapy mua loa o ka honua e huli ana i kahi ʻano subtype o ALS.

Hōʻike ka noiʻi hou loa ʻaʻole hiki i ka hiamoe lōʻihi ke alakaʻi i ka luhi a me ka emi ʻana o ka hoʻomanaʻo, akā hiki ke hoʻonui i ka pilikia o ka maʻi o Alzheimer. Ua ʻike nā kānaka ʻepekema i ka wā hiamoe, hoʻomaka ka lolo i kahi "ʻano hoʻomaʻemaʻe" e wehe i nā protein ʻino, a ʻo ka noho ʻana i ka pō e hoʻopilikia i kēia kaʻina hana, e wikiwiki ana i ka emi ʻana o ka cognitive.

ʻO ka hōʻike hou loa mai ka WHO e hōʻike aku nei e wikiwiki ana ka pilikia o ke kū'ē antibiotic. Inā ʻaʻole e hoʻoponopono koke ʻia, hiki ke make i nā ʻumi miliona o ka honua i nā makahiki he ʻumi e hiki mai ana, e hoʻoweliweli ana i ke kumu o ka ʻōnaehana olakino hou.

Ua ʻae ʻo EU i ka breakthrough Alzheimer's drug donanemab, i hōʻike ʻia i ka emi ʻana o ka cognitive e 35%, akā ʻo kāna kumukūʻai makahiki he $30,000 e hoʻonui ai i nā hopohopo no ka poʻe maʻi ma ka honua holoʻokoʻa.

Nui nā ʻāina o ʻApelika e hoʻolaha nei i ka maʻi maʻi malaria mua loa o ka honua (RTS,S/AS01) ma ke ʻano nui, me ka manaʻo e hāʻawi i ka pale koʻikoʻi no nā keiki mai kēia maʻi maʻi e hoʻopiʻi ai i nā haneli haneli o ka make i kēlā me kēia makahiki. Hōʻike kēia neʻe i kahi holomua nui i ka hoʻolaha anti-malaria honua.